 Cost Sharing
"Cost Sharing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Provisions of an insurance policy that require the insured to pay some portion of covered expenses. Several forms of sharing are in use, e.g., deductibles, coinsurance, and copayments. Cost sharing does not refer to or include amounts paid in premiums for the coverage. (From Dictionary of Health Services Management, 2d ed)
| Descriptor ID |
D017047
|
| MeSH Number(s) |
N03.219.151.170 N03.219.521.576.090
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cost Sharing".
Below are MeSH descriptors whose meaning is more specific than "Cost Sharing".
This graph shows the total number of publications written about "Cost Sharing" by people in this website by year, and whether "Cost Sharing" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 | | 2001 | 0 | 2 | 2 | | 2003 | 0 | 1 | 1 | | 2005 | 0 | 1 | 1 | | 2006 | 1 | 1 | 2 | | 2007 | 1 | 1 | 2 | | 2008 | 2 | 0 | 2 | | 2011 | 1 | 0 | 1 | | 2020 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Cost Sharing" by people in Profiles.
-
Nair KV, Wolfe P, Valuck RJ, McCollum MM, Ganther JM, Lewis SJ. Effects of a 3-Tier Pharmacy Benefit Design on the Prescription Purchasing Behavior of Individuals With Chronic Disease. J Manag Care Spec Pharm. 2020 May; 26(5):575-585.
-
Sabik LM, Vichare AM, Dahman B, Bradley CJ. Co-payment policies and breast and cervical cancer screening in Medicaid. Am J Manag Care. 2020 02; 26(2):69-74.
-
Heo JH, Rascati KL, Lee EK. Prediction of Change in Prescription Ingredient Costs and Co-payment Rates under a Reference Pricing System in South Korea. Value Health Reg Issues. 2017 May; 12:7-19.
-
Gastala NM, Wingrove P, Gaglioti A, Petterson S, Bazemore A. Medicare Part D: Patients Bear The Cost Of 'Me Too' Brand-Name Drugs. Health Aff (Millwood). 2016 07 01; 35(7):1237-40.
-
Park H, Rascati KL, Lawson KA, Barner JC, Richards KM, Malone DC. Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis. J Manag Care Spec Pharm. 2015 Oct; 21(10):956-64.
-
Schmittdiel JA, Nichols GA, Dyer W, Steiner JF, Karter AJ, Raebel MA. Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system. Med Care. 2015 Apr; 53(4):332-7.
-
Yang W, Kahler KH, Fellers T, Orloff J, Chang J, Bensimon AG, Wu EQ, Fan CP, Yu AP. Copayment level, treatment persistence, and healthcare utilization in hypertension patients treated with single-pill combination therapy. J Med Econ. 2011; 14(3):267-78.
-
Steiner JF. Can we identify clinical predictors of medication adherence... and should we? Med Care. 2010 Mar; 48(3):193-5.
-
Page RL, Barton P, Nair K. Effect of cost-sharing for prescription medications on health outcomes in older adults: a critical review of the literature and potential implications for managed care. Consult Pharm. 2008 Jan; 23(1):44-54.
-
Bae SJ, Paltiel AD, Fuhlbrigge AL, Weiss ST, Kuntz KM. Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic medicaid population. Value Health. 2008 Jan-Feb; 11(1):110-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|